Colossal Biosciences announced on March 4, 2025, that it had created what it calls the “Colossal Woolly Mouse,” a living ...

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Tether has invested $20 million in Mercado Bitcoin, backing the Brazilian platform's expansion into tokenized assets, ...

The biotechnology company will use the federal pilot program for its planned $2 billion Saratoga Springs manufacturing campus ...

PROTACs have helped redefine what may be possible in drug discovery. By harnessing the ubiquitin-proteasome system to ...

A Japanese biotech company is testing a drug designed to do what modern dentistry has never managed: regrow real, natural ...

Tvardi Therapeutics (Nasdaq: TVRD) shares surge after Phase 1 results show TTI-109 matched TTI-101's exposure with better tolerability and clear STAT3 target engagement.

Researchers review how 3D printed hydrogel bioelectronics can improve sensing, adhesion and soft tissue interfaces in medical ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...

Futurists and science fiction writers have predicted privately funded missions to Mars for decades, but until recently, the ...

DENTSPLY SIRONA is on a conditional recovery watch, rated Hold with a bullish bias, pending clear evidence of turnaround.